Literature DB >> 6779473

The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.

J R Andersen, E Schroeder, P E Lebech.   

Abstract

25 women aged 53--78 years with at least two years menopause were divided in three groups receiving one of the following oral treatments for three weeks: 2 mg oestradiol-17 beta plus 1 mg oestriol, 4 mg oestradiol-17 beta plus 2 mg oestriol or 50 micrograms ethinyloestradiol daily. Blood samples were collected before, during and after the treatment and the effect on the serum concentration of prolactin, oestradiol-17 beta, follicle-stimulating hormone and luteinizing hormonee was evaluated. During treatment with natural human oestrogens serum oestradiol-17 beta levels were significantly higher than before treatment. The serum concentration of prolactin was unchanged in patients receiving 2 mg oestradiol-17 beta plus 1 mg oestriol but increased in patients receiving 4 mg oestradiol-17 beta plus 2 mg oestriol or 50 micrograms ethinyl-oestradiol, thus indicating dose-dependence for natural human oestrogens. However, the increase was moderate, and these higher levels were not significantly different from levels of prolactin in serum found in 16 younger women. Concentrations of follicle-stimulating hormone and luteinizing hormon were depressed during treatment, the former to significantly lower levels when higher doses of oestrogens were used.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779473     DOI: 10.1530/acta.0.0950433

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

Review 1.  Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention.

Authors:  N F Boyd; L J Martin; J Stone; C Greenberg; S Minkin; M J Yaffe
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 2.  Hyperprolactinaemia.

Authors:  M Hartog; M G Hull
Journal:  BMJ       Date:  1988-09-17

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Estriol affects prolactin and LH secretion in rats.

Authors:  M C Diaz; A Seilicovich; B H Duvilanski; N Siseles; M Lasaga; L Debeljuk
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

5.  Amniotic fluid prolactin, decidual prolactin content and decidual prolactin secretion into hypo-, iso-, and sodium chloride hyperosmotic media in vitro in pregnant diabetics at term.

Authors:  J R Andersen; B Borggaard; E B Olsen; H Stimpel; H C Nyholm; E Schroeder
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

6.  The association of breast mitogens with mammographic densities.

Authors:  N F Boyd; J Stone; L J Martin; R Jong; E Fishell; M Yaffe; G Hammond; S Minkin
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.